QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Breast CancerBreast TumorsMetastatic Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- NantCell, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT00626106
- Locations
- 🇬🇧
Research Site, Peterborough, United Kingdom
QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors
Phase 2
Completed
- Conditions
- Ewing's SarcomaPrimitive Neuroectodermal Tumors (PNETs)SarcomaAskin's TumorsDesmoplastic Small Round Cell TumorsEstraosseous Ewing's TumorEwing's Family Tumor
- Interventions
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- NantCell, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00563680
© Copyright 2025. All Rights Reserved by MedPath